The Net Margin of ReShape Lifesciences Inc (RSLS) is -89.06%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -89.06% |
| 2023-12-31 | -131.22% |
| 2022-12-31 | -411.12% |
| 2021-12-31 | -464.34% |
| 2020-12-31 | -775.47% |
| 2019-12-31 | -721.95% |
| 2018-12-31 | -410.77% |
| 2017-12-31 | -350.86% |
| 2016-12-31 | -603.83% |
| 2015-12-31 | -385.15% |